肥厚性心肌病与缺血性心脏病无关，但是50%的病例具有家族性并且与基因突变有关。突变基因一般为心脏收缩过程先关基因。
Hypertrophic cardiomyopathy is not related to ischemic heart disease but 50% of cases are familial and may be related to genetic mutations in genes encoding for cardiac contractile elements.
家族性肥厚型心肌病是一种以常染色体显性遗传为特征的具有遗传异质性的心脏疾病，它是年轻人心源性猝死的首要病因。
Familial hypertrophic cardiomyopathy (FHCM) is a genetically heterogeneous cardiac disease transmitted as an autosomal dominant trait. It is the leading cause of sudden cardiac death (SCD) in youth.
已发现至少有13种基因的突变可导致家族性肥厚型心肌病，加深对其分子遗传学的认识有利于促进该病的诊断和治疗。
At least 13 genes mutation has now been identified to cause FHCM. Understanding the molecular genetics mechanisms will provide new avenues for diagnosis and treatment for FHCM.
目的研究中国人家族性肥厚型心肌病(HCM)的致病基因突变位点，分析基因型与临床表型的相互关系。
Objective to study the disease-causing gene mutations in Chinese hypertrophic cardiomyopathy (HCM) and to reveal the relationship between the genotype and the phenotype.
摘要 ：MYBPC3基因突变是家族性肥厚型心肌病的原因之一。
Abstract : The MYBPC3 gene mutations can cause hypertrophic cardiomyopathy (HCM).
摘要 ：MYBPC3基因突变是家族性肥厚型心肌病的原因之一。
Abstract : The MYBPC3 gene mutations can cause hypertrophic cardiomyopathy (HCM).
应用推荐